Pulse Biosciences, Inc.
PLSE · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $95 | $106 | $119 | $118 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $0 | $2 | $2 | $1 |
| Total Curr. Assets | $97 | $108 | $121 | $119 |
| Property Plant & Equip (Net) | $7 | $8 | $8 | $8 |
| Goodwill | $3 | $3 | $3 | $3 |
| Intangibles | $1 | $1 | $1 | $1 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1 | $1 | $1 | $1 |
| Total NC Assets | $12 | $12 | $12 | $13 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $109 | $120 | $133 | $132 |
| Liabilities | – | – | – | – |
| Payables | $3 | $3 | $2 | $2 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $0 | $3 | $3 | $1 |
| Total Curr. Liab. | $10 | $9 | $8 | $10 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $6 | $7 | $7 | $8 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $8 | $8 | $9 | $9 |
| Total Liabilities | $16 | $16 | $15 | $18 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$446 | -$426 | -$407 | -$391 |
| AOCI | -$0 | $0 | $0 | $0 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $93 | $104 | $118 | $115 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $109 | $120 | $133 | $132 |
| Net Debt | -$95 | -$106 | -$119 | -$118 |